Novartis reported CHF3.75B in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Alcon AG ALC:SW 890M 36M
Amgen AMGN:US $ 1637M 147M
AstraZeneca AZN:LN 2193M 273M
Bayer BAYN:GR € 4546M 152M
Biogen BIIB:US $ 459.7M 18.4M
Bristol Myers Squibb BMY:US $ 2451M 52M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Fresenius FRE:GR € 6628M 102M
Fresenius Medical Care FME:GR € 3036M 33M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 851M 513M
Hikma Pharmaceutical HIK:LN 600M 2M
Johnson & Johnson JNJ:US $ 7587M 551M
Lonza Group LONN:SW 1.5B 690M
Merck MRK:GR € 1813M 92M
Merk MRK:US $ 2684M 771M
Novartis NOVN:VX SF 3754M 79M
Novartis NVS:US $ 3754M 79M
Orion ORNBV:FH 99.6M 15.1M
Pfizer PFE:US $ 6992M 2820M
Philips PHIA:NA € 2441M 101M
Recordati REC:IM 101.87M 2.2M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M